Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,296.80 -10.32 -0.07%
S&P 500 1,649.33 -6.02 -0.36%
Nasdaq 3,458.92 -4.38 -0.13%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: GreTai Sec M
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Orient Pharma Co Ltd

+ Add to Watchlist

4166:TT

45.85 TWD 0.85 1.82%

As of 02:54:06 ET on 05/23/2013.

Snapshot for Orient Pharma Co Ltd (4166)

Open: 46.13 Day's Range: 45.85 - 46.30 Volume: 38,250
Previous Close: 46.70 52wk Range: 15.30 - 61.50 1-Yr Rtn: -

Stock Chart for 4166

No chart data available.
  • 4166:TT 45.85
  • 1D
  • 1M
  • 1Y
46.70
Interactive 4166 Chart

Previous Close

Key Statistics for 4166

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TWOTCI -
Earnings Per Share (ttm) -1.1800
Est. EPS -
Est. PEG Ratio -
Market Cap (M TWD) 7,702.80
Shares Outstanding (M) 168.00
30 Day Average Volume 46,741
Price/Book (mrq) 5.6997
Price/Sale (ttm) 51.5551
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4166

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4166

Orient Pharma Company Ltd. is a pharmaceutical company. The Company offers drugs to treat acid reflux, cold, and pain management.

Tsai Cheng-HungChairmanTsai Meng-LinCEO/President
Lu Chih-ChengPresident:OperationHsiao Yu-ChienVP:R & D
More Company Profile & Key Executives for 4166

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil